Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
Times Cited: 34
Times Cited: 34
Times Cited
Times Co-cited
Similarity
Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
72
'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.
L Henneman, D R Timmermans, C M Bouwman, M C Cornel, H Meijers-Heijboer. Public Health Genomics 2011
L Henneman, D R Timmermans, C M Bouwman, M C Cornel, H Meijers-Heijboer. Public Health Genomics 2011
45
Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
38
Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
32
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
32
The WISDOM Study: breaking the deadlock in the breast cancer screening debate.
Laura J Esserman. NPJ Breast Cancer 2017
Laura J Esserman. NPJ Breast Cancer 2017
29
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
26
Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
64
"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.
Jocelyn Lippey, Louise A Keogh, G Bruce Mann, Ian G Campbell, Laura E Forrest. Cancer Prev Res (Phila) 2019
Jocelyn Lippey, Louise A Keogh, G Bruce Mann, Ian G Campbell, Laura E Forrest. Cancer Prev Res (Phila) 2019
66
Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
David P French, Jake Southworth, Anthony Howell, Michelle Harvie, Paula Stavrinos, Donna Watterson, Sarah Sampson, D Gareth Evans, Louise S Donnelly. Br J Cancer 2018
David P French, Jake Southworth, Anthony Howell, Michelle Harvie, Paula Stavrinos, Donna Watterson, Sarah Sampson, D Gareth Evans, Louise S Donnelly. Br J Cancer 2018
33
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
41
The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
20
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
25
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
38
Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
17
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
17
Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
17
A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
17
Developing and evaluating polygenic risk prediction models for stratified disease prevention.
Nilanjan Chatterjee, Jianxin Shi, Montserrat García-Closas. Nat Rev Genet 2016
Nilanjan Chatterjee, Jianxin Shi, Montserrat García-Closas. Nat Rev Genet 2016
17
Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
17
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
17
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
50
How Do Women View Risk-Based Mammography Screening? A Qualitative Study.
Xiaofei He, Karen E Schifferdecker, Elissa M Ozanne, Anna N A Tosteson, Steven Woloshin, Lisa M Schwartz. J Gen Intern Med 2018
Xiaofei He, Karen E Schifferdecker, Elissa M Ozanne, Anna N A Tosteson, Steven Woloshin, Lisa M Schwartz. J Gen Intern Med 2018
42
Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
17
Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study.
S F Meisel, L Side, L Fraser, S Gessler, J Wardle, A Lanceley. Public Health Genomics 2013
S F Meisel, L Side, L Fraser, S Gessler, J Wardle, A Lanceley. Public Health Genomics 2013
25
Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
14
Risk determination and prevention of breast cancer.
Anthony Howell, Annie S Anderson, Robert B Clarke, Stephen W Duffy, D Gareth Evans, Montserat Garcia-Closas, Andy J Gescher, Timothy J Key, John M Saxton, Michelle N Harvie. Breast Cancer Res 2014
Anthony Howell, Annie S Anderson, Robert B Clarke, Stephen W Duffy, D Gareth Evans, Montserat Garcia-Closas, Andy J Gescher, Timothy J Key, John M Saxton, Michelle N Harvie. Breast Cancer Res 2014
14
The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
14
Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
31
Dutch women's intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers.
Linda Rainey, Daniëlle van der Waal, Mireille J M Broeders. BMC Cancer 2020
Linda Rainey, Daniëlle van der Waal, Mireille J M Broeders. BMC Cancer 2020
55
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
Hatef Darabi, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, Keith Humphreys. Breast Cancer Res 2012
Hatef Darabi, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, Keith Humphreys. Breast Cancer Res 2012
11
Polygenes, risk prediction, and targeted prevention of breast cancer.
Paul D P Pharoah, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder. N Engl J Med 2008
Paul D P Pharoah, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder. N Engl J Med 2008
11
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
11
Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.
A E Hall, S Chowdhury, N Hallowell, N Pashayan, T Dent, P Pharoah, H Burton. J Public Health (Oxf) 2014
A E Hall, S Chowdhury, N Hallowell, N Pashayan, T Dent, P Pharoah, H Burton. J Public Health (Oxf) 2014
13
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
11
Assessing and managing breast cancer risk: clinicians' current practice and future needs.
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
12
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
11
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
John T Schousboe, Karla Kerlikowske, Andrew Loh, Steven R Cummings. Ann Intern Med 2011
John T Schousboe, Karla Kerlikowske, Andrew Loh, Steven R Cummings. Ann Intern Med 2011
11
Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
11
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
11
Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
14
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
11
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Amy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, Diana L Miglioretti, Clyde B Schechter, Mehmet Ali Ergun, Jeroen J van den Broek, Oguzhan Alagoz, Brian L Sprague, Nicolien T van Ravesteyn,[...]. Ann Intern Med 2016
Amy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, Diana L Miglioretti, Clyde B Schechter, Mehmet Ali Ergun, Jeroen J van den Broek, Oguzhan Alagoz, Brian L Sprague, Nicolien T van Ravesteyn,[...]. Ann Intern Med 2016
11
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.
J Gagnon, E Lévesque, F Borduas, J Chiquette, C Diorio, N Duchesne, M Dumais, L Eloy, W Foulkes, N Gervais,[...]. Curr Oncol 2016
J Gagnon, E Lévesque, F Borduas, J Chiquette, C Diorio, N Duchesne, M Dumais, L Eloy, W Foulkes, N Gervais,[...]. Curr Oncol 2016
21
Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
22
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
30
Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
11
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
11
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
11
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.